Brii Biosciences Company Description
Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
The company develops BRII-179, a recombinant protein-based HBV immunotherapeutic candidate; Elebsiran, an investigational subcutaneously administered HBV-targeting siRNA; and Tobevibart, an investigational subcutaneously administered HBV-neutralizing monoclonal antibody which are in Phase 2 of the development stage for functional cure of HBV for Hepatitis B; and BRII-732 that has completed Phase 1 clinical trial and BRII-753, which is in preclinical stage for the treatment of HIV.
It also develops BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative bacterial infections, which has completed Phase 1; and Epetraborole for oral treatment for patients with chronic NTM lung disease.
Brii Biosciences Limited was incorporated in 2017 and is headquartered in Beijing, China.
| Country | Cayman Islands |
| Founded | 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 98 |
| CEO | Zhi Hong |
Contact Details
Address: Building 7, International Science Park Beijing, 100192 China | |
| Website | briibio.com |
Stock Details
| Ticker Symbol | BRIBF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG1645A1094 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zhi Hong Ph.D. | Co-founder, Executive Chairman of the Board and Chief Executive Officer |
| Dr. Ankang Li C.F.A., J.D., Ph.D. | Chief Financial and Strategy Officer, Joint Secretary and Executive Director |
| Dr. Eleanor de Groot Ph.D. | Chief Technology Officer |
| Dr. Brian Alvin Johns Ph.D. | Chief Scientific Officer |
| Sarah Qiu | Associate Director of Investor Relations |
| Karen Del Barrio Neuendorff | Chief People Officer and Head of Human Resources |
| Dr. Qing Zhu Ph.D. | Head of China Research and Development |
| Dr. David Margolis M.D., M.P.H. | Chief Medical Officer |
| Dr. Susannah Cantrell Ph.D. | Chief Business Officer |
| Wing Tsz Ho CGP, FCIS, FCS, M.B.A., P.E. | Joint Company Secretary |